Lintuzumab

lintuzumab · Seagen Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Lintuzumab, covering 2011-10-12 to 2014-12-18. Get the full timeline:

Most recent: Clinical Trial Update: A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome [Phase 1]